Press Releases

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

FREDERICK, Md., June 16, 2021 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments … Read more

Betamore & FITCI Expand Founder City

Pitch Competition Deadline Extended & Final Celebration Moved to Fall 2021

Baltimore, MD and Frederick, MD: Founder City, an impactful, hybrid conference-event created in collaboration by Betamore and Frederick Innovative Technology Center, Inc. (FITCI) has expanded its weekly programming and is extending its pitch competition deadline, thanks to strong support from regional entrepreneurs, fellow incubators and industry leaders. Founder City brings together some of the most essential pillars of the startup … Read more

Coinbase adds Tellor, a Frederick-based cryptocurrency startup

Frederick MD – There’s been a lot of buzz about cryptocurrency, Bitcoin, and NFTs (non-fungible tokens) these days, and even small, mainstream investors are taking note, but one Maryland startup is playing the long game. Frederick-based Tellor started in March 2019, founded by Nicholas Fett, Brenda Loya, and Michael Zemrose. Fett’s background as a former … Read more

BioSolution Designs Raises Seed Round

BioSolution Designs closes initial Seed Round of funding to accelerate its ongoing product invention activities.

Frederick, MD., May 5, 2021 — BioSolution Designs, LLC, announces that initial Seed Round goals are met and full operation begins as of May 1. BSD Founder and President, Dr. Thomas Reed, will direct use of the funding to accelerate existing collaborative initiatives developed over the past year. These efforts are focused on inventing biotools useful for drug discovery … Read more

Minnodi Empowers Women

Frederick, MD: Santhanalakshmi Shanmugam appreciates the unique challenges women face when entering the workforce, especially in the demanding fields of science and technology. She founded Minnodi, LLC, a Maryland-based Women Owned Business focusing on IT/Pharma consulting and staffing agency headquartered at the Frederick Innovative Technology Center, Inc. (FITCI), to help business leaders and potential employees connect. Now, she’s … Read more

Betamore & FITCI Announce Founder City

Baltimore, MD and Frederick, MD: Betamore and Frederick Innovative Technology Center, Inc. (FITCI) have announced their collaboration on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into one event some of the most essential pillars of the startup community; demos, pitches, capital, mentorship and connection. From April thru May, weekly programming focused … Read more

Leading diagnostics laboratory in the Caribbean selects NextGenPCR for SARS-CoV-2 testing

Clinical implementation of ultra-fast molecular testing improves time to result and laboratory throughput

Goes, Netherlands, March 31, 2021 — Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that Aruba’s Laboratorio di Servicio (LdS) has validated and implemented NextGenPCR for SARS-CoV-2 testing. With a single NextGenPCR system capable of producing over 1,000 results per day, Laboratorio di Servicio has ensured they have capacity beyond their current 300 … Read more

M Power Education Records Explosive Growth During the COVID-19 Pandemic

Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company grew from three to fifteen employees and expanded their client base as well as student enrollment – they have 7x more students enrolling in their … Read more

Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005

FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for VLX-1005 for the treatment of heparin induced thrombocytopenia (HIT). “We are pleased … Read more

Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia

FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a Phase 1 clinical trial of VLX-1005, a … Read more